Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005203947
Tue, 18.03.2025
BRAIN Biotech AG
Results of the 2025 Annual General Meeting for the 2023/24 financial year of BRAIN Biotech AG
ZWINGENBERG, March 18, 2025 – At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items with a broad majority. Dr. Anna C. Eichhorn and Stephen Catling [ … ]
Wed, 26.02.2025
BRAIN Biotech AG
BRAIN Biotech AG: 3M FY 24/25 - Starting the year with double digit sales growth in the core BRAINBiocatalysts division
BRAINBiocatalysts organic growth at 11 % in Q1
Quantitative guidance looking at strong growth and solid adjusted EBITDA margin for BRAINBiocatalysts in FY 2024/25
Strong cash position maintained at € 17.8 million while reducing [ … ]
Thu, 13.02.2025
BRAIN Biotech AG
Biological gold recycling: BRAIN Biotech AG collaborates with PX Group on the PX Urban Mining Initiative
Development of BioXtractor V2 pilot by BRAIN and PX Group and production of first BioGold nuggets from a local waste stream
Extension of cooperation between the two companies as part of the PX Urban Mining Initiative
PX Urban Mining Initiativ [ … ]
Wed, 15.01.2025
BRAIN Biotech AG
Annual Report 2023/24: BRAIN Biotech AG acts from a strong cash position and is confident about its growth prospects
Group cash and cash equivalents improved to € 27.2 million
Successfully closed two milestone transactions with Royalty Pharma and Akribion Therapeutics
Management sees a strong start to the new financial year
Updated mid-term tar [ … ]